Highlights
- •Virginia observed an increase in the incidence of Candida auris from 2020-2021.
- •Most new cases identified in a ventilator skilled nursing facility (vSNF).
- •Two clades were identified, indicating distinct C. auris introductions.
- •Regional facilities should collaborate on infection prevention and control practices.
- •vSNFs must prioritize multidrug-resistant organism prevention strategies.
Abstract
Candida auris, an emerging multi-drug resistant organism (MDRO), is an urgent public health threat.
We report on a C. auris outbreak investigation at a Virginia ventilator skilled nursing facility (vSNF).
During October 2020–June 2021, we identified 28 cases among residents in the ventilator
unit. Genomic evidence suggested ≥2 distinct C. auris introductions to the facility. We identified multiple infection and prevention control
challenges, highlighting the importance of strengthening MDRO prevention efforts at
vSNFs.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to American Journal of Infection ControlAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Incidence and management of Candida Auris in a skilled nursing home.Am J Infect Control. 2020; 48: S15-S16https://doi.org/10.1016/j.ajic.2020.06.128
- First reported outbreak of the emerging pathogen Candida auris in Canada.Am J Infect Control. 2021; 49: 804-807https://doi.org/10.1016/j.ajic.2021.01.013
- A description of the first Candida auris-colonized individuals in New York State.Am J Infect Control. 2016; 47 (-2017): S10https://doi.org/10.1016/j.ajic.2019.04.155
Pennsylvania Department of Health. Alert: New outbreak and containment of Candida auris in PA healthcare facilities; 2020 [cited 2021 Aug 13]. Available from: https://www.health.pa.gov/topics/Documents/HAN/2020-PAHAN-522-08-18-ALT-Candida%20aur.pdf
- Candida auris outbreak in a COVID-19 specialty care unit — Florida, July–August 2020.MMWR Morb Mortal Wkly Rep. 2021; 70: 56-57https://doi.org/10.15585/mmwr.mm7002e3
- Notes from the field: Transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities ― Texas and the District of Columbia, January–April 2021.MMWR Morb Mortal Wkly Rep. 2021; 70: 1022-1023https://doi.org/10.15585/mmwr.mm7029a2
Centers for Disease Control and Prevention. Tracking Candida auris; 2021 [cited 2021 Sept 21]. Available from: https://www.cdc.gov/fungal/candida-auris/tracking-c-auris.html
- Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: A molecular epidemiological survey.Lancet Infect Dis. 2018; 18: 1377-1384https://doi.org/10.1016/S1473-3099(18)30597-8
- National Notifiable Diseases Surveillance System (NNDSS) Candida auris 2019 Case Definition.Reviewed. April 16, 2021;
Centers for Disease Control and Prevention. Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs). Updated January 2019. https://www.cdc.gov/hai/pdfs/containment/Health-Response-Contain-MDRO-H.pdf
Article info
Publication history
Publication stage
In Press Journal Pre-ProofIdentification
Copyright
© 2023 Published by Elsevier Inc. on behalf of Association for Professionals in Infection Control and Epidemiology, Inc.
